Drugs Lessen Multiple Sclerosis Damage in Mice

Posted on by admin

Artist’s representation of oligodendrocyte. Drugs Lessen Multiple Sclerosis Damage in Mice
In a mouse study, 2 drugs already on the market activated stem cells and repaired the type of brain damage seen in multiple sclerosis. The finding might lead to novel therapies.
SOURCE: NIH Research Matters – Read entire story here.

Related posts:

  1. Researchers identify 763 proteins in human aqueous humor that nourish the cornea and the lens Researchers conducting a comprehensive proteomics analysis of human aqueous humor samples identified 763 proteins - including 386 proteins detected for the first time - in this clear fluid that helps maintain pressure in the eye and nourishes the cornea and the lens. ...
  2. Rugby players wear head sensors in new concussion study Randwick Rugby Club players are wearing bio sensors behind their ears so doctors and coaches can measure the impact of hits on the field as part of a new study into concussion in sport. ...
  3. Lipid Nanoparticle Therapeutic Treats Ebola in Monkeys Lipid Nanoparticle Therapeutic Treats Ebola in MonkeysA newly designed agent was effective in treating monkeys infected with a deadly Ebola virus strain. The therapy is now being tested in Sierra Leone in people infected with Ebola. ...
  4. Tumor DNA in Blood Reveals Lymphoma Progression Tumor DNA in Blood Reveals Lymphoma ProgressionUsing an advanced genetic test, researchers detected diffuse large B-cell lymphoma in blood before it could be seen on CT scans. The technique could improve disease monitoring. ...
  5. Interpreting Breast Biopsies Interpreting Breast BiopsiesPathologists asked to interpret a difficult set of breast biopsy slides accurately made most diagnoses, but the results suggest strategies for future improvement. ...

Related Posts

Colorectal cancer genetically different in older and younger patients

While the overall rate of colorectal cancer (CRC) is declining, CRC specifically among young patients is increasing. Previous studies have shown that CRC in patients younger than 50 years old tends to be more aggressive than CRC in older patients. A new study offers early evidence of genetic differences between CRC in young and old patients, possibly pointing toward different treatments and strategies in combating the young form of the disease.